Ubiquitination is a central process affecting all facets of cellular signalling and function 1 . A critical step in ubiquitination is the transfer of ubiquitin from an E2 ubiquitin-conjugating enzyme to a substrate or a growing ubiquitin chain, which is mediated by E3 ubiquitin ligases. RING-type E3 ligases typically facilitate the transfer of ubiquitin from the E2 directly to the substrate 2,3 . The RING-between-RING (RBR) family of RING-type E3 ligases, however, breaks this paradigm by forming a covalent intermediate with ubiquitin similarly to HECT-type E3 ligases 4-6 . The RBR family includes Parkin 4 and HOIP, the central catalytic factor of the LUBAC (linear ubiquitin chain assembly complex) 7 . While structural insights into the RBR E3 ligases Parkin and HHARI in their overall auto-inhibited forms are available 8-13 , no structures exist of intact fully active RBR E3 ligases or any of their complexes. Thus, the RBR mechanism of action has remained largely unknown. Here we present the first structure, to our knowledge, of the fully active human HOIP RBR in its transfer complex with an E2~ubiquitin conjugate, which elucidates the intricate nature of RBR E3 ligases. The active HOIP RBR adopts a conformation markedly different from that of auto-inhibited RBRs. HOIP RBR binds the E2~ubiquitin conjugate in an elongated fashion, with the E2 and E3 catalytic centres ideally aligned for ubiquitin transfer, which structurally both requires and enables a HECTlike mechanism. In addition, three distinct helix-IBR-fold motifs inherent to RBRs form ubiquitin-binding regions that engage the activated ubiquitin of the E2~ubiquitin conjugate and, surprisingly, an additional regulatory ubiquitin molecule. The features uncovered reveal critical states of the HOIP RBR E3 ligase cycle, and comparison with Parkin and HHARI suggests a general mechanism for RBR E3 ligases.
RBR E3 ligases are characterized by an extended RING domain (RING1) followed by an 'in-between RING' (IBR) domain and the catalytic domain, which is structurally an IBR domain but is commonly designated RING2 (Extended Data Fig. 1a, b) [8] [9] [10] [11] 14 . HOIP, one of the most studied RBRs, is the key E3 ligase of the linear ubiquitin chain assembly complex (LUBAC). It is a prototypical RBR yet contains an extended RING2 domain that includes the LDD (linear ubiquitin chain determining domain, Extended Data Fig. 1c ) [5] [6] [7] 14 and is thus denoted RING2L. The LDD enables the selective formation of linear ubiquitin linkages. The HOIP RBR is kept in an auto-inhibited state by the HOIP UBA domain, whose sequestration by the LUBAC constituent HOIL-1L activates HOIP to trigger, together with SHARPIN, NF-κB signalling and other cellular processes [5] [6] [7] [15] [16] [17] [18] [19] [20] . To obtain the first insight into an active RBR in a key catalytic complex, we generated a stable E2~ubiquitin conjugate (UbcH5B C85K~ubiquitin) 21 and isolated its complex with HOIP RBR. The subsequent addition of free ubiquitin proved necessary for crystal formation, allowing us to solve the HOIP RBR/UbcH5B~ubiquitin transfer complex structure at 3.5 Å resolution ( Fig. 1a ; Extended Data Figs 2 and 3).
The asymmetric unit contains two HOIP RBR molecules interacting with two UbcH5B~ubiquitin conjugates and an additional ubiquitin or E2~ubiquitin conjugate, arranged in a swapped dimer configuration (Extended Data Fig. 3a ). While this arrangement could have functional relevance, analysis of interfaces and biophysical examination (Extended Data Fig. 3b-f ) indicate a monomeric assembly of the HOIP/E2~ubiquitin loading complex ( Fig. 1) , represented in the crystal structure by the RING1-IBR module (residues 699-852) from one HOIP molecule and the RING2L (residues 853-1,072) from the second HOIP molecule in the asymmetric unit. In this assembly, the RING1-IBR module forms an elongated arm-like unit ( Fig. 2a) The RBR RING1 and IBR together with two RING1 extension helices (h E1 , h E2 ) form an arm-like unit (magenta; for domain annotations see Extended Data Fig. 1 ). The RING1-IBR and the catalytic RING2L (green) are connected by two linker helices (h L1 , h L2 ) and together engage the E2~ubiquitin conjugate (UbcH5B~Ub act ; orange and cyan, respectively) positioning it for ubiquitin transfer onto the RBR catalytic cysteine (yellow circle). An allosteric ubiquitin molecule (Ub allo , blue) binds to the RING1-IBR across from the activated ubiquitin. Zinc ions are shown as grey spheres; h R denotes the RING1 helix. b, Location of the three ubiquitin-binding regions (UBRs, dashed lines) in the complex. together with the RING2L embraces the E2~ubiquitin conjugate in a clamp-like manner (Fig. 1a ). This active HOIP RBR conformation is markedly different from previous structures of auto-inhibited RBRs (Extended Data Fig. 1d ) and enables an astounding array of features inherent to the active RBR. Most notably, three distinct helix-IBR-fold motifs function as essential discrete ubiquitin-binding regions (UBR) (Fig. 1b) .
The HOIP RING1/E2 interaction is tailored towards a HECT-like mechanism, setting it apart from classic RING E3 ligases. While RING/ E2 interactions of both classic RING and RBR E3 ligases utilize similar surfaces (Extended Data Fig. 4a ) [21] [22] [23] [24] [25] [26] , the position of the HOIP RING1 domain relative to the E2 is shifted compared to classic RING/E2 complexes ( Fig. 2b) . Therefore, the RBR RING1 and the E2 do not form a composite surface to bind the E2-conjugated activated ubiquitin (Ub act , Extended Data Fig. 4b, c, e ), which is key to the mechanism of classic RING E3 ligases 21, 24, 27 . Instead, two extension helices (h E1 , h E2 ) link the RBR RING1 to the IBR domain (Figs 1 and 2a) [8] [9] [10] [11] , and helix h E2 with the IBR forms an UBR (UBR1) that engages the activated ubiquitin ( Fig. 2c and Extended Data Fig. 5a, b ). UBR1 binds ubiquitin in a distinctive mode (mode 1) that utilizes a salt bridge system involving HOIP h E2 residues K783 and E787 and ubiquitin residues K11 and E34, with further support from the HOIP IBR ( Fig. 2c and Extended Data Fig. 5b ). Thus, in HOIP the entire RING1-IBR arm mediates bipartate binding of the E2~ubiquitin conjugate, with RING1 binding the E2 and the h E2 -IBR module binding activated ubiquitin ( Fig. 2a ). Sequence and structural comparisons with Parkin and HHARI suggest conservation of this mechanism among RBR E3 ligases (Extended Data Figs 4c and 5c). Importantly, the bipartite binding mode results in an elongated conformation of the E2~ubiquitin conjugate with its thioester linkage not suited for direct attack by the amine function of a substrate ( Fig. 2d and Extended Data Fig. 4e-f ). The consequence is an entirely different catalytic arrangement compared to classic RING-supported catalysis, as emphasized by the observed lack of effect of mutations in UbcH5B L104 and S108, two residues crucial for classic RING/E2 catalysis 21, 25, 26 (Extended Data Fig. 4d ). Instead, the E2~ubiquitin thioester is ideally positioned for transfer of the activated ubiquitin onto HOIP RING2L, thus both enabling and requiring a HECT-like mechanism. The importance of each interaction site is demonstrated in thioester transfer and polyubiquitination assays, where mutation of key RING1 and UbcH5B residues drastically impairs RBR activity ( Fig. 2e- ; one-way ANOVA followed by Tukey's post-test; **P < 0.01; ***P < 0.001; Supplementary  Fig. 1 ) and linear polyubiquitination (f) assays of HOIP RBR wild type (WT) and interface mutants, and HOIP catalytic domain (RING2L). g. Thioester transfer and linear ubiquitin assays for UbcH5B wild type and RING1 interaction mutant F62A (Coomassie-stained bands in red). activity ( Fig. 2e , f), indicating a cumulative effect due to a potential role of UBR1 in coordinating Ub act in steps subsequent to its initial transfer to HOIP. However, removal of the salt bridge in HOIP/ubiquitin double mutants and mutation of the HOIP IBR/Ub act interface cause the expected drastic reduction in thioester transfer activity (Extended Data Fig. 5d -f).
The other portion of the RBR/E2~ubiquitin embrace is centred around the catalytic HOIP RING2L (Figs 1a and 3a) . Here a helix-IBR-fold motif consisting of helix h L2 from the IBR-RING2L linker and RING2L form a second UBR (UBR2) binding the activated ubiquitin ( Fig. 3a and Extended Data Fig. 6a -c). UBR2, which is conserved in Parkin and HHARI (Extended Data Fig. 6d ), uses a hydrophobic pattern in helix h L2 and RING2 to interact with the canonical (I44) and a second hydrophobic patch 28 of ubiquitin (Extended Data Fig. 6b-e ). These interactions support the engagement of the ubiquitin R72/R74 di-Arg motif by polar residues, which is the key characteristic of UBR binding mode 2. This ultimately places the ubiquitin C terminus onto RING2 (Extended Data Fig. 6b, d ) and thus the ubiquitin/E2-thioester linkage onto the RBR active site. A previous structure 14 of the isolated HOIP RING2L with two ubiquitin molecules bound in a linear noncovalent arrangement mimics the final HOIP RING2L donor/acceptor ubiquitin transfer complex ( Fig. 3b and Extended Data Fig. 6f ). Remarkably, in this structure the donor ubiquitin adopts a position identical to the activated ubiquitin in HOIP UBR2 despite lacking the h L2 interaction (Extended Data Fig. 6f ). This indicates that the binding mode of the activated ubiquitin observed in the HOIP/E2~ubiquitin complex persists from the E2~ubiquitin/E3 HOIP transfer complex to the HOIP~ubiquitin/acceptor ubiquitin transfer complex. The E2 portion of the E2~ubiquitin conjugate instead interacts with a region of RING2L that overlaps with that observed for the acceptor ubiquitin in the second transfer reaction ( Fig. 3b and Extended Data Fig. 6f ). Thus, the binding of E2~ubiquitin and of acceptor ubiquitin/substrate are mutually exclusive, requiring formation of a covalent HECT-like RBR~ubiquitin intermediate in the RBR E3 ligase cycle.
Importantly, the HOIP RBR/E2~ubiquitin complex structure lacks the spatial gap between the E2 and E3 catalytic centres that is frequently observed in HECT/E2 complex structures and that was also predicted for RBR/E2~ubiquitin transfer complexes [8] [9] [10] [11] 28, 29 . Thus, except for the ~3.5 Å spacer due to the C85 to lysine substitution in the E2~ubiquitin conjugate, the HOIP RBR/E2~ubiquitin structure accurately depicts the immediate transfer complex. Here the catalytic centres of HOIP RING2L and E2 come in close proximity via two contact conduits involving all three proteins ( Fig. 3c and Extended Data Fig. 7a ). The first conduit consists of ubiquitin R72, which interacts with D983 and Q974 in the β5/6-hairpin of HOIP RING2L. Additionally, E976 in this hairpin mediates a salt bridge with ubiquitin R74 and UbcH5B R90, thus facilitating interactions among all three proteins. The second conduit consists of catalytic residues of UbcH5B (N77, D117) and HOIP (H887, Q896) 5, 6, 10, 14, [21] [22] [23] [24] 26 . These residues appear permissive to close proximity between the reaction centres, yet not crucial for transesterification because, for example, a H887A mutation does not affect the thioester transfer reaction 10, 14 (Extended Data Fig. 7b) . Surprisingly, mutation to alanine of UbcH5B D117, a critical residue for classic RING-supported catalysis 21, 24 , enhances transesterification (Extended Data Fig. 7b ), further underlining the vastly different catalytic mechanism of RBR E3 ligases. This finding also points to a trade-off in the E2 active site to support both classic ; one-way ANOVA followed by Tukey's post hoc test; **P < 0.01; ***P < 0.001; NS, not significant; Supplementary Fig. 1 ). c, Polyubiquitination assays showing release of HOIP UBA-RBR auto-inhibition by HOIL-1L or linear di-ubiquitin. d, Effect of wild-type HOIP or UBR3 mutants in NF-κB reporter assays using HEK293T cells expressing full-length HOIP with or without HOIL-1L (mean activity ± s.e.m. of three biological replicates each with three technical replicates; one-way ANOVA followed by Tukey's post hoc test; ***P < 0.001; Extended Data Fig. 9f ). RING-and HECT-type RBR E3 ligases. Notably, UbcH7, which is specialized for HECT-like E3 catalysis 4 , features a histidine instead of D117 (Extended Data Fig. 7a ). Mutational analysis demonstrates a crucial role for conduit 1 and also indicates that the close proximity between the ubiquitin thioester (and thus C85 of UbcH5B) and HOIP catalytic cysteine C885 is the driving factor for E2/RBR E3 ubiquitin transfer ( Fig. 3c, d and Extended Data Fig. 7 ). Analysis of Parkin and HHARI shows conservation of the conduits (Extended Data Fig. 7a ). However, while Parkin and HHARI lack the β5/6-hairpin indigenous to HOIP RING2L, they instead possess a pair of conserved polar residues in the RING2 active site loop that are capable of binding the di-Arg motif in conduit 1. Surprisingly, our structure reveals that an additional allosteric ubiquitin molecule (Ub allo ) interacts with a third HOIP UBR. UBR3 is located in the RING1-IBR arm immediately across UBR1 and Ub act (Figs 1b, 4a and Extended Data Fig. 8a, b ). Ub allo uses a binding mode similar to that of Ub act with UBR2 (mode 2), characterized by hydrophobic interactions and a di-arginine binding clamp (Extended Data Fig. 8a ). Ub allo interacts with helix h E2 of the extended RING1 and with the IBR, and makes additional interactions with helix h E1 ( Fig. 4a and Extended Data Fig. 8c ). Through this binding, Ub allo induces a 'straight' conformation of helix h E2 locking RING1 and IBR in their relative position, forming UBR1 to accommodate the activated ubiquitin ( Fig. 4a and Extended Data Fig. 8b-d ). Notably, UBR3 in the HOIP RBR/UbcH5B~ubiquitin complex binds linear di-ubiquitin (K d = 7 μM) better than mono-ubiquitin (K d > 50 μM) (Extended Data Fig. 9a ). Pre-incubation of HOIP RBR with linear di-ubiquitin leads to improved binding of UbcH5B~ubiquitin (Extended Data Fig. 9b ), emphasizing the allosteric function of UBR3. Accordingly, HOIP UBR3 I807A and E809A mutants show moderately decreased activity in thioester transfer assays but more pronounced effects in polyubiquitination assays, where linear di-ubiquitin/polyubiquitin are intrinsically produced ( Fig. 4b and Extended Data Fig. 9c ). Importantly, N-and C-terminally capped linear di-ubiquitin increases HOIP RBR thioester transfer activity in a dose-dependent manner, but cannot activate HOIP UBR3 mutants ( Fig. 4b and Extended Data Fig. 9d ). Moreover, the linear di-ubiquitin I44A mutant also fails to activate HOIP RBR (Extended Data Fig. 9d ).
Excitingly, the interaction of Ub allo with UBR3 is structurally similar to that recently reported for phospho-ubiquitin in a tethered complex with ΔUBL Pediculus humanus Parkin 13 (Extended Data Fig. 8c-e ). Binding of phospho-ubiquitin leads to a straight conformation of Parkin helix h E2 and an accompanying reorientation of RING1 and IBR, indicating a general role of UBR3 and ubiquitin in allosteric regulation of RBR proteins. Functionally, binding of phospho-ubiquitin activates Parkin by counteracting the auto-inhibitory function of the Parkin UBL domain (Extended Data Fig. 8c -e) 13 . In HOIP, the UBA domain exerts intramolecular auto-inhibition 5, 6 . While the structure of auto-inhibited HOIP is unknown, the structure of auto-inhibited HHARI shows binding of its UBA domain to a region analogous to UBR3 (Extended Data Fig. 8f -h) 11 . To determine if linear di-ubiquitin can overcome HOIP auto-inhibition, we examined its effect on HOIP UBA-RBR. As expected, HOIP UBA-RBR alone exhibits low E3 activity but is activated by HOIL-1L ( Fig. 4c ). Notably, linear di-ubiquitin can also remove HOIP UBA auto-inhibition and at high concentrations allows the processive formation of polyubiquitin chains by HOIP UBA-RBR ( Fig. 4c ). Importantly, in HEK293T cells expressing full-length HOIP, the HOIP UBR3 I807A and E809A mutants fail to activate NF-κB regardless of HOIL-1L expression, demonstrating an essential physiological role of UBR3 ( Fig. 4d ). Thus, UBR3 probably serves as a critical sensor of ubiquitin chains that regulates LUBAC function. Whether this role is tailored to linear ubiquitin chains or ubiquitin chains in general (Extended Data Fig. 9b , e) needs further investigation in the context of other LUBAC constituents and binding partners.
The features revealed by the HOIP RBR/E2~Ub act /Ub allo complex structure provide the missing links in our understanding of these enigmatic multidomain E3 ligases [8] [9] [10] [11] 14 and yield a mechanistic model for the RBR E3 ubiquitin ligase cycle, as summarized in Extended Data Fig. 10 . Furthermore, the conservation of key mechanistic features in HOIP, HHARI, Parkin and other RBRs (Supplementary Data 2) underlines the general nature of the catalytic RBR cycle revealed in this study.
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METHODS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Constructs. Human HOIP and HOIL-1L cDNA were purchased from Open Biosystems (cloneIDs 4653017 and 3877587, respectively). HOIP RBR (residues 696-1,072), HOIP RING2L (residues 853-1,072) and full-length HOIL-1L were cloned into the pET-NKI-6xHis-3C-LIC vector 30 coding for an N-terminal 6×His tag with a 3C protease cleavage site. HOIP UBA-RBR (residues 475-1,072) was cloned into a pET-NKI-6×His-eGFP-3C-LIC vector that codes for a 3C-cleavable His-tagged enhanced green fluorescent protein (eGFP) followed by the HOIP sequence. Human UbcH5B and Cdc34 DNA were a gift from M. Petroski. Coding sequences for UbcH13 and Uev1a were extracted out of a human cDNA library (Agilent Megaman). For crystallization, UbcH5B (residues 2-147) with the mutations S22R (to prevent backside ubiquitin binding 31 ) and C85K (to enable covalent ubiquitin linkage 21 ) was cloned into the pET-NKI-6×His-3C-LIC vector. UbcH5B without S22R and C85K mutations (used for enzymatic assays), Cdc34, UbcH13 and Uev1a were cloned into the same vector. Untagged mono-ubiquitin with native N and C termini, used for crystallization and linear ubiquitination assays, was cloned into the pET29 vector (Novagen) using NdeI/XhoI restriction sites. N-terminally blocked mono-ubiquitin used for thioester assays was cloned in the pET-NKI-6×His-3C-LIC vector. Untagged linear di-ubiquitin was cloned with overlap extension PCR and ligated into the pET29 vector (Novagen) using NdeI/XhoI restriction sites. N-and C-terminally blocked di-ubiquitin with a N-terminal His tag and a C-terminal Ala-Ser sequence was cloned into the pET-NKI-6×His-3C-LIC vector. Human ubiquitin-activating enzyme E1 (Ube1) was cloned into a pET28 vector resulting in an N-terminal His tag. For NF-κB assays full-length HOIP with an N-terminal Flag tag and HOIL-1L with an N-terminal myc tag were cloned into pcDNA3.1(+) (Invitrogen) using EcoRI/NotI restriction sites. Mutations in UbcH5B, ubiquitin and HOIP were introduced using standard site-directed mutagenesis techniques. Protein expression and purification. All proteins were expressed in BL21(DE3) E. coli after induction with 0.5 mM IPTG overnight at 20 °C. For expression of HOIP and HOIL-1L constructs, 0.5 mM ZnCl 2 was added to the cultures before induction. Bacteria were harvested by centrifugation, lysed by addition of lysozyme and sonication in the presence of protease inhibitors (PMSF and leupeptin) and DNase. Lysates were cleared by centrifugation and His-tagged proteins were initially purified using Ni-NTA agarose (Qiagen). For HOIP RBR used for crystallization, and UbcH5B, Cdc34, UbcH13, Uev1a, wild-type ubiquitin to generate K48-linked di-ubiquitin and HOIL-1L His tags were removed by addition of 3C protease overnight at 4 °C. HOIP RBR and HOIL-1L were further purified using Superdex 200 10/300 GL or HiLoad 16/600 Superdex 200 pg size-exclusion chromatography columns (GE Healthcare) equilibrated in protein buffer (10 mM HEPES pH 7.9, 100 mM NaCl). UbcH5B used for biochemical assays was further purified on a Superdex 75 10/300 GL size-exclusion chromatography column (GE Healthcare) equilibrated in protein buffer. HOIP mutants for activity assays, and Cdc34, UbcH13 and Uev1a were desalted into protein buffer directly after Ni-NTA purification using PD MidiTrap G-25 desalting columns (GE Healthcare). Ube1 for biochemical assays was further purified using ion-exchange chromatography (Source Q) in 10 mM HEPES pH 7.9, 10 mM NaCl and eluted with a gradient from 10-500 mM NaCl. N-terminally His-tagged (di-)ubiquitin was purified using Ni-NTA as described above followed by size-exclusion chromatography using a Superdex 75 10/300 GL column (GE Healthcare) equilibrated in protein buffer or buffer exchange into protein buffer using PD MidiTrap G-25 desalting columns. To purify untagged mono-or di-ubiquitin, 0.5 mM EDTA and 100 mM sodium acetate pH 4.5 were added to the bacterial lysates and lysates were cleared by centrifugation, diluted sevenfold with 50 mM sodium acetate pH 4.5 and applied to a Source S 10/100 ion exchange column (GE Healthcare) equilibrated in 50 mM sodium acetate pH 4.5. Ubiquitin was eluted with a 0-500 mM NaCl gradient and further purified by size-exclusion chromatography on a Superdex 75 10/300 GL column (GE Healthcare) equilibrated in protein buffer. His-eGFP-HOIP was purified using size-exclusion chromatography as described for HOIP RBR, followed by 3C cleavage and removal of His-eGFP via a second round of size-exclusion chromatography. All proteins were generally flash frozen in liquid nitrogen in small aliquots and stored at −80 °C. UbcH5B~ubiquitin linkage. UbcH5B~ubiquitin linkage was performed based on published methods 21 . Briefly, Ube1, UbcH5B(S22R/C85K) and ubiquitin were mixed and buffer exchanged into 50 mM Tris pH 10, 150 mM NaCl using PD-10 desalting columns (GE Healthcare). 10 mM MgCl 2 , 5 mM ATP and 1 mM TCEP were added and the protein solution was incubated at 37 °C for 16 h. The completeness of the reaction was monitored using SDS-PAGE and covalently linked UbcH5B~ubiquitin was purified from unreacted proteins and Ube1 using a Superdex 75 10/300 GL size-exclusion chromatography column (GE Healthcare) equilibrated in protein buffer. HOIP RBR/UbcH5B~ubiquitin complex formation. HOIP RBR was mixed with a 1.3-fold molar excess of UbcH5B~ubiquitin and applied to a Superdex 200 10/300 GL size-exclusion chromatography column equilibrated in protein buffer. Complex formation and purity was confirmed using SDS-PAGE, and complex containing fractions were pooled and concentrated to ~12 mg ml −1 for crystallization. HOIP/UbcH5B~ubiquitin/ubiquitin crystallization. Crystallization was performed using the vapour diffusion technique in sitting drop MRC 96-well plates (Molecular Dimensions). Initial crystals were obtained mixing HOIP/ UbcH5B~ubiquitin complex solution with an equimolar amount of free ubiquitin in the Morpheus Screen (Molecular Dimensions). Subsequently, 2 μl of the protein complex were mixed with 0.6 μl reservoir solution (0.1 M Morpheus Buffer 3 pH 8.5 (Tris/Bicine), 0.12 M Morpheus Alcohols Mix (0.02 M each of 1,6-hexanediol; 1-butanol; 1,2-propanediol (racemic); 2-propanol; 1,4-butanediol; 1,3-propanediol), 30% Morpheus P550MME_P20K mix (20% PEG550MME, 10% PEG20K) and 8% glycerol) in MRC 48-well plates (Molecular Dimensions). Crystals appeared after about one week at 12 °C and were cryo-cooled, and evaluated on a rotating anode X-ray generator (Rigaku FR-E superbright). Seeding and dehydration of the crystals was performed to improve crystal diffraction. For successful dehydration, reservoir was slowly added to the protein drop (3 × 0.5 μl within ~2 h) and subsequently equilibrated overnight at 12 °C against a reservoir solution with increased P550MME_P20K concentration by adding 11 μl 60% Morpheus P550MME_P20K stock solution to 50 μl reservoir solution. The new reservoir solution was then slowly added to the protein drop (3 × 0.5 μl, followed by 2 × 1 μl with removal of 1 μl each in the last steps). After further overnight equilibration, crystals were harvested from the drop and directly cryo-cooled in a cryogenic nitrogen stream at 100 K. Crystals diffracted in-house to 4-6 Å. Complete diffraction data were measured at 100 K at beamline 23ID-D of the General Medical Sciences and Cancer Institutes Structural Biology Facility at the Advanced Photon Source (GM/CA @ APS), Argonne National Laboratory. Despite their size (common dimensions of ~200 × 140 × 100 μm 3 ) crystals exhibited substantial inhomogeneity resulting in split and smeared diffraction spots. Using raster scans 32 , a suitable region for data collection could be identified at the edge of the crystal. Using a small (20 μm diameter) beam, split spots could be separated to allow reliable indexing and integration. Utilization of a small beam necessitated higher flux to retain reliable diffraction. To mitigate the radiation damage, the total dose was distributed over a 100-μm stretch of the crystal by using the 'helical' mode of 'vector' data collection as implemented in JBluIce 33 . Data were measured at 1.282 Å wavelength with a Pilatus3 6M pixel array detector with a 1-mm-thick sensor (Dectris). Data processing and structure solution. Data were collected from a single crystal and indexed, integrated and scaled in XDS/XSCALE 34 . Data were further processed using AIMLESS 35 from the CCP4 suite 36 with a resolution cut-off of 3.48 Å, resulting in an 〈 〉= . 14) ) with the four C-terminal residues deleted. Various ambiguous solutions were identified that could not be separated, and Zn 2+ sites could not be identified using MR-SAD due to incompleteness of resultant models. However, manual inspection revealed that some MR solutions contained ubiquitin oriented near identically to the symmetry-related donor ubiquitin observed in the HOIP RING2L/ubiquitin-ubiquitin transfer complex (PDB: 4LJP (ref. 14) ). Based on this observation, a trimmed search model was created that contained a complex of the core of HOIP RING2L (with residues 906-924 and 949-999 removed) and C-terminally truncated ubiquitin. An MR search using this model found a single solution for two copies of the complex. After successful iterative searches for two UbcH5B molecules and two further ubiquitin molecules, MR-SAD using Phaser identified 15 distinct Zn 2+ sites including the known Zn 2+ sites in the RING2L domain of HOIP. Further molecular replacement in Phaser using a single unit of the initial HOIP RING2L/UbcH5B~ubiquitin complex (without the additional second ubiquitin), and the NMR structure of HOIP IBR (zinc atoms removed, deposited in Protein Data Bank 40 under PDB accession number 2CT7, unpublished) correctly placed a single HOIP IBR domain, which was then manually copied to the other NCS-related HOIP in the asymmetric unit. For molecular replacement of the HOIP RING1, Sculptor 41 was used to generate a search model based on the structure of the RING1 domain of HHARI (PDB: 4KBL (ref. 11)). However, Phaser was not able to correctly place this domain, probably owing to the low sequence conservation of only 27% identity. However, since mutational analysis of HOIP suggested that the RING/E2 interaction is preserved between RING-type E3 ligases and RBR-type E3 ligases 5 , we overlaid the E2 of the published RNF4-RING/UbcH5A~ubiquitin structure (PDB: 4AP4 (ref. 21)) with the E2 in our structure and then used this overlay to add the RING1 model generated by Sculptor. This overlay placed the HOIP RING1 Zn 2+coordinating residues near the last remaining free Zn 2+ ions found earlier by Phaser MR-SAD, indicating correct placement of the RING1 domain. In the final round of molecular replacement, the two additional ubiquitin (Ub allo ) molecules were reinstated at the RING1-IBR interface. At this stage, Refmac 42 was used for refinement using settings optimized for low-resolution refinement 43 including 'jelly body refinement' and Babinet scaling. ProSMART 44 was used to generate external restraints against high-resolution structures (PDB: 4LJO (ref. 14) for HOIP RING2L and ubiquitin, and PDB: 2ESK (ref. 45) for UbcH5B). After this, clear extra electron density became visible for the unmodelled helical linker regions of the RING1-IBR and IBR-RING2L transitions and for other regions omitted in the initial search models. Further model building and refinement was manually performed in Coot 46 and Refmac. During refinement additional clear positive difference map electron density became visible and Phaser was used to place one additional UbcH5B molecule (UbcH5B add ) into this density. TLS restraints were generated using the TLSMD server 47 and NCS restraints were used throughout refinement. One overall B-factor was refined in Refmac. In later rounds of refinement the PDB_REDO server 48 was used for refinement optimization and MolProbity 49 was used for structure validation. Data processing and refinement statistics are summarized in Extended Data Fig. 2b . Ramachandran statistics were calculated using MolProbity and 94.8% of all residues are in favoured regions, 4.9% in allowed regions and 0.3% are outliers. The final structure has a MolProbity score of 1.75 (100th percentile). In the final structure the two HOIP RBR molecules (see also Extended Data Fig. 3 ) are defined by electron density from residues 699 to 707, 711 to 948, 969 to 991, and 996 to 1,011 (chain A) and 699 to 754, 760 to 957, 967 to 1,015, 1,019 to 1,035 and 1,054 to 1,066 (chain B). The catalytic UbcH5B~ubiquitin conjugates are defined from UbcH5B residues 3 to 147 and ubiquitin residues 1 to 76 (chains C and E), and UbcH5B residues 2 to 147 and ubiquitin residues 1 to 76 (chains D and F). The allosteric ubiquitin chains (chains G and H) are defined from residues 1 to 76 and the additional UbcH5B (chain I) is defined from residues 2 to 146. PHENIX was used to calculate simulated annealing (SA) composite omit maps and feature enhanced maps (FEM). All molecular figures were prepared in PyMOL (Schrödinger, LLC). K48-linked and K63-linked ubiquitin chain formation. K48-linked and K63linked ubiquitin chains were formed through a linkage-specific enzymatic reaction using Cdc34 and UbcH13/Uev1a E2 ubiquitin-conjugating enzymes, respectively, as described in the literature 50 . Ubiquitin chains were separated using ion-exchange chromatography as described above for purification of mono-ubiquitin. Purified K48-linked di-ubiquitin was directly desalted into protein buffer using PD-10 desalting columns, whereas K63-linked di-ubiquitin was further purified on a Superdex 75 10/300 GL size-exclusion chromatography column equilibrated in protein buffer. Native ubiquitin without additional residues was used to generate di-ubiquitin chains for ITC experiments, whereas N-terminally blocked ubiquitin was used to form K48-linked di-ubiquitin for testing allosteric activation of HOIP RBR. Linear polyubiquitination assay. Linear ubiquitin formation assays were performed in 50 mM HEPES pH 7.9, 100 mM NaCl, 10 mM MgCl 2 and 0.6 mM DTT using 200 nM E1, 1 μM UbcH5B, 1 μM HOIP RBR or HOIP RING2L and 40 μM untagged ubiquitin. Reactions were started by addition of 10 mM ATP and were incubated at 30 °C for 2 h. Samples were taken at the indicated time points and treated with 50 mM sodium acetate pH 4.5 as described previously 6 , mixed with SDS sample buffer and analysed by SDS-PAGE using 12% Bolt Bis-Tris gels (Life Technologies). Proteins were visualized with Coomassie Brilliant blue dye. To test the activating effect of linear di-ubiquitin on auto-inhibited HOIP UBA-RBR, 5 μM HOIP UBA-RBR was pre-incubated with N-and C-terminally blocked linear di-ubiquitin or HOIL-1L at the indicated concentrations before addition of the remaining assay components. Samples were taken after 60 min and subsequently treated as described above. UbcH5B~ubiquitin to HOIP RBR ubiquitin transfer assay. To monitor HOIP~ubiquitin thioester ubiquitin transfer from UbcH5B to HOIP, Ube1 (100 nM), UbcH5B (4 μM) and N-terminally blocked ubiquitin (32 μM) were mixed in 50 mM HEPES pH 7.9, 100 mM NaCl, 10 mM MgCl 2 and 5 mM ATP and incubated at 25 °C for 5 min when 2 μM HOIP RBR was added. Samples were taken 10 s after HOIP addition, quenched by addition of pre-heated SDS protein-loading buffer without DTT, and run on a 12% SDS-PAGE gel (Life Technologies). The 10-s time point used was empirically determined with a time-course experiment (Extended Data Fig. 9g ). Gels were stained with Coomassie Brilliant blue dye and scanned on a Li-COR Odyssey scanner using the 700 nm (red) channel. For the thioester transfer assay shown in Fig. 3d, 200 nM Ube1, 2 μM UbcH5B, 8 μM HOIP RBR, 8 μM N-terminally blocked ubiquitin and 10 mM ATP were used and samples taken after 30 s. Furthermore, proteins were transferred to a PVDF membrane and ubiquitin was visualized on a LI-COR Odyssey scanner at 800 nm using an anti-ubiquitin antibody (P4D1, Santa Cruz, 1:200 dilution in TBST (50 mM Tris pH 7.4, 150 mM NaCl, 0.05% Tween-20)) followed by an IRDye 800CW secondary antibody (LI-COR, 1:10,000 dilution in TBST). All quantitative experiments shown in graphs were performed in triplicates and band intensities were quantified using the ImageStudio software (LI-COR). HOIP thioester transfer activity was calculated as the fraction of HOIP~ubiquitin to total HOIP for each mutant and normalized against thioester transfer activity of wild-type HOIP. Data were analysed in GraphPad Prism using two-tailed unpaired Student's t-test or one-way ANOVA followed by Tukey's post hoc test. Allosteric activation of HOIP RBR by di-ubiquitin. To test the allosteric activation of HOIP RBR by linear di-ubiquitin, a modified ubiquitin transfer assay was performed. HOIP RBR was pre-incubated with N-and C-terminally blocked linear di-ubiquitin at the indicated final concentrations for 5 min at 25 °C. At the same time, Ube1, UbcH5B, ubiquitin and ATP were premixed and incubated for 5 min at 25 °C, resulting in fully loaded UbcH5B~ubiquitin. Both mixtures were subsequently mixed together, resulting in final concentrations of 100 nM Ube1, 2 μM UbcH5B, 8 μM N-terminally blocked ubiquitin and 2 μM HOIP RBR in the final buffer described for the standard ubiquitin transfer assay. Samples were taken after 30 s and further treated as described for the standard transfer assay. A 30-s time point was determined to give the best results in this assay, in which lower E2 and mono-ubiquitin concentrations were used, resulting in an overall slower reaction rate. The experiments comparing the effects of linear versus K48-linked di-ubiquitin (Extended Data Fig. 9e ) were performed similarly, with the difference that all samples were incubated with apyrase (Sigma) for 5 min to deplete ATP before addition of HOIP/di-ubiquitin and prevent E2-loading of K48-linked di-ubiquitin, which features a free C terminus on one of the ubiquitin units. 
NF-κB luciferase assay. Human embryonic kidney (HEK) 293T cells (ATCC)
were co-transfected with NF-κB-luc reporter plasmid that contains an NF-κB response element upstream of the promoter driving the luciferase reporter gene, pGL4.74[hRluc/TK] control vector (Promega) and epitope tagged Flag-HOIP or myc-HOIL-1L pcDNA3.1(+) plasmids in 6-well plates in triplicates using Lipofectamine 2000 transfection reagent. Since this assay could be carried out in a variety of cellular contexts, HEK293T cells were used because they are easy to transfect and suitable for the assay. The cells tested negative for mycoplasma contamination. Empty pcDNA3.1(+) vector was used as control. After 36 h, cells were lysed and 20 μl cell lysates were used to measure firefly luciferase and Renilla luciferase (transfection control) signals using the dual luciferase reporter assay system according to the manufacturer's protocol (Promega). Data were analysed in GraphPad Prism and one-way ANOVA followed by Tukey's post hoc tests were used for statistical analysis. Immunoblotting was performed with anti-Flag (clone M2, Sigma-Aldrich) and anti-myc (clone 9E10, Sigma-Aldrich) antibodies, to confirm equivalent wild-type and mutant protein expression levels. Fig. 1. b , Data collection and refinement statistics. Figure 3 | Complexity of the crystallographic asymmetric unit and structure of the HOIP/UbcH5B~ubiquitin/ ubiquitin E2-E3 transfer complex. a, The asymmetric unit contains two transfer complexes. Left, colour schematic of the proteins present in the asymmetric unit. Middle, structure of the asymmetric unit. The asymmetric unit contains two HOIP RBR/UbcH5B~ubiquitin complex arrangements (complex 1, 2). The two UbcH5B~ubiquitin conjugates are coloured orange and cyan, respectively, and are bound to two HOIP RBR molecules (magenta and green), which cross over between the complexes. Additional allosteric ubiquitin (Ub allo , blue) and UbcH5B~ubiquitin (UbcH5B~Ub allo , yellow and blue, respectively) molecules are bound to the HOIP RBRs in complex 1 and complex 2, respectively. Since Ub allo makes all contacts with the RBRs and the UbcH5B of the UbcH5B~Ub allo conjugate solely mediates crystal contacts (bottom left), only Ub allo of complex 1 is displayed and discussed in the text and figures in terms of the additional ubiquitin binding. The black oval indicates an additional HOIP h L1 /Ub act inter-complex interaction discussed in panels e and f. Right, close-up of the region where the two RBRs of HOIP cross over between the complexes. The close-up shows that residues D852 and P853 of the respective RBRs come in 6 Å proximity suggesting a continuity in the biological complex in which the two residues from the respective RBRs are linked (as indicated by the grey background), resulting in the monomeric complex schematically illustrated underneath and discussed in panels c-f. b, The RING1-IBR and RING2L form two distinct entities to bind E2~ubiquitin. The monomeric complex as displayed for complex 1 assumes a flexible linkage between the autonomous units of the RING1-IBR arm and the RING2L from the two different RBR molecules in the asymmetric unit. This linkage is formed by residues D852 and P853 connecting IBR and RING2L (schematically illustrated in the cartoon). To test the structural integrity of the assumed link and the autonomy of the RING1-IBR arm on one side and the RING2L on the other side, we introduced a spacer comprising five alanine residues between D852 and P853 in HOIP RBR (see cartoon) and measured the activity of the RBR D852-Ala 5 -P853 insertion mutant in polyubiquitination assays. The assays show that the mutant (right) retains an activity similar to the wildtype RBR (left) indicating that indeed RING1-IBR and RING2L act as autonomous units. The dramatically reduced activity of HOIP RING2L alone (residues P853 to end) is also shown for reference (middle). c, The HOIP RBR/UbcH5B~ubiquitin complex is monomeric at concentrations of 1.25-5 μM. To determine if the HOIP RBR/UbcH5B~ubiquitin complex is indeed monomeric in solution, we analysed the isolated HOIP RBR/UbcH5B~ubiquitin complex protein material that was used for crystallization by sedimentation equilibrium analytical ultracentrifugation (SE-AUC). SE-AUC provides an absolute, shape-independent measurement of molecular weight, thus allowing accurate determination of the oligomeric state. The three SE-AUC experiments performed on the HOIP RBR/UbcH5B~ubiquitin complex yielded an absolute molecular weight (MW) of 71,658 Da, indicating a monomeric complex. At an order of magnitude higher concentrations (12.5-50 μM), SE-AUC results indicate the formation of a dimer with a MW of ~144 kDa, although curve fitting residuals also show substantial presence of aggregates (data not shown). These results indicate that the biological complex in solution is monomeric at physiological low μM concentrations such as those used for the thioester transfer assays and polyubiquitination assays. However, the dimeric arrangement observed in the crystal structure might be relevant in a high concentration setting such as within the LUBAC complex. Here, a high local concentration of HOIP RBR could favour binding of the E2~ubiquitin between the RING1-IBR and RING2L of two neighbouring molecules. Importantly, all mechanisms depicted in this article hold true for both the monomeric and dimeric states (as illustrated in d). This means that the deduced mechanism is in principle applicable to different RBR E3 ligases of which some might function as dimers in local high concentration assemblies (such as within the LUBAC), whereas others might be active in a monomeric setting. d, Schematic illustration of the dimeric arrangement as observed in the asymmetric unit. The schematic shows that all features deduced (Figs 1-4 and Extended Data Figs 4-10) are also valid for the dimeric case (binding of Ub allo is omitted for clarity). e, Asymmetric unit dimer-related interactions between HOIP h L1 and Ub act . The dimeric arrangement contains no additional protein-protein interfaces compared to the monomeric assemblies with the exception of h L1 residues W847, M850 and N851, which in the asymmetric unit contact the activated ubiquitin of the other complex (indicated by an oval in a). f, Mutational analysis of HOIP h L1 /Ub act interactions. Mutations of HOIP h L1 residues that interact with Ub act have no effect on thioester transfer activity (Coomassie-stained bands in red), indicating that this 'trans' complex interaction is not critical for the RBR mechanism, in line with the model of a monomeric arrangement. Figure 4 | The HOIP RING1-IBR applies an altered binding mode compared to classic RING E3s necessitating a HECTlike mechanism. a, The HOIP RBR RING1 uses an E2 interaction pattern similar to classic RINGs, but which results in a shifted binding. Shown are the details of the RING/E2 interaction in the HOIP RING1 RBR /UbcH5B~ubiquitin complex (left), the RNF4 RING classic / UbcH5A~ubiquitin complex (middle; PDB: 4AP4 (ref. 21)), and the BIRC7 RING classic /UbcH5B~ubiquitin complex (right; PDB: 4AUQ (ref. 24) ). The HOIP RBR-type RING1 uses a pattern of hydrophobic residues as the core of the interaction with E2 that is similar to that in classic RING E3 ligases. Subtle differences however support a shifted binding mode (see also Fig. 2b) . The main features of the RING and E2 as well as HOIP residues mutated in Fig. 2e -g are displayed in bold. Zinc-finger (ZF) 1 and 2 of the RING domains and the SPA-loop of the E2 containing a conserved Ser-Pro-Ala motif are annotated. For the following panels the same structures and colour codes as in a are used. b, The shift in binding and altered surface residues in HOIP RING1 do not support the composite RING/E2 binding site for activated ubiquitin used by classic RING/E2 complexes. UbcH5A/B E2s are rendered as surface representation and the RING domains in ribbon representation. Residues crucial for classic RING E3s to recruit the activated ubiquitin in the composite RING/ E2 ubiquitin-binding surface 21, 24 are depicted (middle, right). In HOIP RING1 (left) equivalent residues are not conserved (displayed), indicating that HOIP cannot accommodate the activated ubiquitin in its RING1/ UbcH5B complex. For illustration purposes, only one monomer of the dimeric RNF4 is shown (although Y193 from the other RING molecule is still displayed) 21 ; for BIRC7 the RING dimer (RING 2 ) is displayed 24 . c, Alignment of HOIP, Parkin and HHARI RING1 domains with classic RING domains centred around residues displayed in b. Residues crucial for ubiquitin binding in classic RINGs are highlighted in cyan and their structural equivalents in the RING1 domains of the RBR E3 ligases HOIP, Parkin and HHARI are indicated by boxes, attesting to the absence of a composite RING1/E2 ubiquitin-binding site in RBR ligases (asterisk indicates ubiquitin interaction residues from the other RING molecule in the dimers formed by the classic RINGs RNF4 and BIRC7). The T/I-C-R sequence observed in the dimeric RINGs of RNF4 and BIRC7 represents the highly conserved Φ-x-R/K motif, where Φ is a hydrophobic residue and x is either a Cys in RING E3 ligases or a polar residue in U-box ligases 26 . This motif is not only critical for E3-mediated catalysis by dimeric RING ligases (such as RNF4 or BIRC7) but is also necessary for E2-mediated catalysis by simpler monomeric RING and U-Box E3 ligases 26 . The fact that this motif is not conserved in HOIP, HHARI and Parkin further confirms the mechanistic differences between RBRs and classic RING domains. d. Thioester transfer assays show that E2 residues critical for classic RING-supported catalysis are not important for HOIP catalysis. Left, HOIP RBR thioester transfer assays show similar activity of wild-type UbcH5B and L104A and S108A mutants. This is in stark contrast to the reported effects of these mutations on classic RING-supported catalysis 21, 24 , underlying the fundamentally different mechanism of the HECT-like catalysis by HOIP RBR. Right, mutation to Ala of HOIP RBR N909, which would be in the vicinity of the activated ubiquitin if the E2~ubiquitin conjugate were bound in a bent manner (see e), also shows no effect on HOIP thioester formation (Coomassiestained bands in red). e, The altered E2~ubiquitin binding mode of RBR RING1 results in the requirement for a HECT-like mechanism. Displayed are the entire RING/UbcH5~ubiquitin complexes with RINGs and E2 s depicted in ribbon representation and the activated ubiquitin in surface representation. The bipartite binding mode used by the HOIP RING1h E2 -IBR arm (see also Fig. 2a ) results in an elongated E2~ubiquitin conformation (left, only the RING1 domain of HOIP is depicted) while formation of a composite RING/E2 binding surface in the case of classic RING E3 ligases (middle, right) results in binding of the activated ubiquitin in a compact manner with a bent E2~ubiquitin conformation. Importantly, this bent conformation places the thioester link in a specific position relative to the catalytic machinery of the E2, allowing direct attack by the lysine/amine function of a substrate or growing ubiquitin chain. The Lys85/Ser85 residues mediating the E2~ubiquitin linkage and mimicking UbcH5A/B catalytic cysteine C85 are displayed as red spheres. In the elongated E2~ubiquitin conformation propagated by the HOIP RBR, this attack is not possible. The linkage is however ideally positioned for the attack by the RBR catalytic cysteine in a HECT-like mechanism (see also Fig. 3 and Extended Data Fig. 7a ). f, Close-up of the catalytic centres in E2~ubiquitin linkages. Details of the catalytic centres resulting from the E2~ubiquitin conjugate conformations outlined in e and, for comparison, the HECT-type E3 NEDD4L/UbcH5B~Ub structure (PDB: 3JW0 (ref. 28)), with the directionality of an attacking amine indicated as previously proposed 21 . In the HECT-like RBR arrangement, the UbcH5B~ubiquitin linkage is not aligned correctly relative to the E2 catalytic machinery for a direct attack by an amine function. This is similar in the HECT-type arrangement in the NEDD4L complex but completely different from the arrangement in classic RING-supported E2 catalysis. Additionally, the ubiquitin C-terminal residues G75-G76 reside in a position that would overlap with the attacking amine. The available structure of the BIRC7/ UbcH5B~Ub complex (PDB: 4AUQ (ref. 24)) features an UbcH5B N77A mutant and the remainder of the Asn side-chain has been manually added based on wild-type UbcH5B from PDB: 2ESK (ref. 45) (right). Figure 5 | Helix-IBR-fold motifs constitute new ubiquitin-binding regions (UBR) in active RBR proteins: binding of the activated ubiquitin by UBR1 using binding mode 1. a, Schematic illustrating binding mode 1 used by h E2 -IBR to bind the activated ubiquitin in the RING1-IBR arm. The general principle of this binding mode is that the RING1 extension helix 2 (h E2 ) preceding the IBR presents a pattern of charged/polar residues (indicated by blue and red squares, which symbolize K, R, H and E, Q, N residues respectively) that interact with ubiquitin E34 and K11. These interactions are supported by the IBR surface, with a particular contribution of hydrophobic residues (yellow square) flanking the salt bridge system. b, Coordination of the activated ubiquitin by HOIP h E2 -IBR in mode 1. HOIP h E2 residues K783 and E787 bind ubiquitin residues E34 and K11 and are flanked by hydrophobic residues M791 and W798 from HOIP IBR. c, Structurally equivalent residues in Parkin and HHARI. Displayed are the h E2 -IBR modules from auto-inhibited Parkin (PDB: 5C1Z (ref. 12)) and HHARI (PDB: 4KBL (ref. 11)) with residues equivalent to HOIP residues in b depicted, illustrating the general conservation of UBR1. It should be noted that these structures feature auto-inhibited forms of the RBR proteins, which exhibit a kink in h E2 of UBR1. This kink would sterically hinder ubiquitin binding to UBR1 and probably participates in the RBR auto-inhibition mechanism (see also Extended Data Fig. 8 ). d, Thioester-transfer assays of ubiquitin and UBR1 salt bridge mutants. In agreement with the observed four-residue salt bridge system in b, the single K11A or E34A ubiquitin mutations show only a slight to moderate effect since the remaining charged residue can still coordinate the two oppositely charged residues of HOIP. In contrast, elimination of both similarly charged residues in the complex by combining the HOIP K783A and ubiquitin K11A or HOIP E787A and ubiquitin E34A mutations results in a more dramatic loss of activity (mean activity ± s.e.m. (n = 3), one-way ANOVA followed by Tukey's post hoc test; **P < 0.01; ***P < 0.001; NS, not significant; representative gels shown in Supplementary Fig. 1 ). e, f, Role of the IBR in UBR1. Close-up of the additional IBR/Ub act interactions in stick representation (e) shows that HOIP S803 and ubiquitin K6 coordinate the backbone carbonyl functions of ubiquitin T12 and HOIP A800/K829, respectively. W798, which is involved in hydrophobic interactions, is also displayed in sphere representation. Quantitative thioester transfer assays (f) show that alanine mutants of residues outlined in e cause a significant loss of activity (mean activity ± s.e.m. (n = 3), left: one-way ANOVA followed by Tukey's post hoc test, right: two-tailed unpaired Student's t-test; **P < 0.01; ***P < 0.001; representative gels shown in Supplementary Fig. 1 ). Mechanistically, the conduits allow for the RBR catalytic cysteine and the E2 catalytic cysteine~ubiquitin linkage to be in close proximity, which serves as main driving force of the transesterification reaction. A reaction driven mainly by proximity is also in agreement with the chemical nature of the catalytic cysteine, which has a pK a of ~8 for the free amino acid. This allows the cysteine to naturally deprotonate, without an absolute need for HOIP H887 (refs 10, 14) , before attack of the ubiquitin G76 carbonyl function. In addition, the thioester linkage is far more labile than for example an amide bond, thus further facilitating a proximitymediated reaction 56 . However, in light of the geometric arrangement observed, additional subtle catalytic contributions of H887 in supporting the transition state of the reaction and/or re-protonation of the E2 catalytic cysteine are in principle possible. This prospect is particularly intriguing because UbcH7 exhibits a potential break in conduit 2 (between H887 and H119), yet provides its 'own' histidine (H119) to the catalytic centre. b, Thioester transfer assays for HOIP contact conduit mutants. Left, thioester transfer assays show that the D983A and E976A mutations strongly affect activity. This is consistent with D983 forming the di-Arg binding motif in UBR2 (see Extended Data Fig. 6 ) and E976 bridging the three proteins in the complex. In contrast, the H887A mutation does not have a marked effect, in agreement with published results 10, 14 . The Q974A mutation also does not have a strong effect, pointing to a weak auxiliary function of this residue in support of the critical D983 (Coomassie-stained bands in red). Right, the UbcH5B R90A mutation shows a moderate yet significant effect, in line with the structure, which suggests a more pronounced effect for HOIP E976A than for UbcH5B R90A. Surprisingly, mutation of the catalytic D117 in UbcH5B, which is essential for classic RING-supported catalysis, shows a positive effect on the HECT-like thioester transfer, further emphasizing a separate mechanism for RBR HECT-like catalysis (as outlined in Fig. 2 and Extended Data Fig. 4 ). The gain of function of the D117A mutation also points to a trade-off for this E2 residue to participate in the classic RING-supported versus RBR HECT-like E2/E3 mechanisms (mean activity ± s.e.m. (n = 3), two-tailed unpaired Student's t-test; **P < 0.01; representative gels shown in Supplementary Fig. 1) c, Polyubiquitination assays for HOIP contact conduit alanine mutants. These assays show similar activity profiles as the thioester transfer assays except for the H887A mutation, which is essential for amide bond formation in the second transfer reaction 10, 14 .
Extended Data

Extended Data Figure 8 | The h E2 -IBR module contains an additional UBR (UBR3) that binds an allosteric ubiquitin using binding mode 2. a, UBR3 binds the allosteric ubiquitin (Ub allo ) using binding mode 2. Cartoon depicting the overall features of binding mode 2 in UBR3. The binding of Ub allo is largely analogous to the binding of the activated ubiquitin by UBR2 in the helix-IBR-fold of h L2 -RING2L (Extended Data Fig. 6a ). Yellow squares indicate hydrophobic patches. b, Location of the UBR3/Ub allo interface in the overall complex and its relation to the UBR1/ Ub act interface. The additional ubiquitin (Ub allo ) binds to UBR3 in the h E2 -IBR module immediately across UBR1 and the activated ubiquitin. The electron density map (feature-enhanced map 57 , grey, contour level σ = 1) for the additional ubiquitin is also depicted on the right. c, Details of the UBR3/Ub allo interaction and its similarity to the interaction of phospho-ubiquitin (pUb) with Pediculus humanus Parkin (Ph-Parkin). Top left, close-up of HOIP UBR3. Ub allo binds to the h E2 -IBR module with additional contacts to h E1 . Depicted are hydrophobic residues of HOIP (V789, L790, F796, W798 and I807) interacting with the ubiquitin canonical hydrophobic patch (L8, I44 and V70/not shown) and a second hydrophobic patch (L71 and L73/not shown), with the critical HOIP I807 emphasized. The di-Arg binding motif is also depicted, with E809 coordinating ubiquitin R72 and R74 and aligning the ubiquitin C terminus in a parallel manner with sheet β2 of the IBR. A red arrow indicates that UBR3 sterically allows the binding of di-ubiquitin/polyubiquitin chains on the C-terminal side of the bound ubiquitin (see also Extended Data Fig. 9 ). Ubiquitin Ser65 is indicated for comparison with the pUb/Ph-Parkin structure (bottom). Top middle, close-up on the di-Arg binding motif. Top right, close-up on the additional contacts between h E1 and Ub allo . HOIP R770 interacts with D766, which makes contacts to Y778, and the backbone carbonyl functions of ubiquitin K63 and E64. Bottom, the recent structure of phospho-ubiquitin bound to Ph-Parkin (PDB: 5CAW (ref. 13)) reveals a similar mechanism. Left, close-up with the residues corresponding to those in HOIP depicted. Middle, close-up of the di-Arg motif. Ph-Parkin D346 coordinates R72 similar to HOIP UBR3/ Ub allo . The chemical tether introduced in the pUb/Ph-Parkin structure between the phospho-ubiquitin C terminus and a non-conserved Cys in Ph-Parkin (C349) shifts ubiquitin R74 away from Ph-Parkin D346 indicating that the di-Arg binding motifs of HOIP and Parkin undergo a similar interaction with ubiquitin or phospho-ubiquitin respectively. Right, the Ph-Parkin interaction equivalent to the HOIP h E1 interaction involves a ubiquitin phospho-serine 65 (pSer65) binding pocket in Ph-Parkin. Phospho-serine 65 is directly coordinated by R307 and Y314 and also H304, which is positioned similarly to HOIP D766. d, The binding of phospho-ubiquitin propagates the formation of UBR1 in Parkin. Overlay of Ub allo (slate) bound to HOIP (magenta) and phospho-ubiquitin (light blue) bound to Ph-Parkin (grey blue). Ubiquitin binding propagates a straight conformation of h E2 and an opening of the IBR relative to the extended RING1 (only h E1 is shown). The tether introduced in the phospho-ubiquitin/Ph-Parkin interaction appears to exert a strain on IBR loop 2 and thus the IBR. This suggests that in the absence of the artificial tether phospho-ubiquitin can propagate the formation of a fully functional UBR1 (binding Ub act ) in Parkin concomitantly to relieving the UBL autoinhibition, as elegantly demonstrated by Komander and colleagues 13 . e, The interaction of phospho-ubiquitin with a site analogous to UBR3 in Ph-Parkin causes a straight conformation of h E2 and reorientation of the IBR relative to RING1 as prerequisite to accommodate the activated ubiquitin. Left, full-length auto-inhibited human Parkin (PBD: 5C1Z (ref. 12)). Right, tethered phospho-ubiquitin in complex with ΔUBL-Ph-Parkin (PDB : 5CAW (ref. 13) ). f, Conservation of UBR3 in HHARI. HHARI features a helix-IBR module similar to that of HOIP, with conserved hydrophobic patches and a polar residue (Q288) in the position of HOIP E809 that is in principle capable of binding the ubiquitin di-Arg motif. The h E2 -IBR region from auto-inhibited HHARI (PDB: 4KBL (ref. 11)) is displayed. As for auto-inhibited Parkin, a key difference from active HOIP is the kink in helix h E2 of auto-inhibited HHARI (see also panel g and Extended Data Fig. 5c ). Taken together, these features indicate an overall similarity and the existence of a UBR3 that is allosterically linked to UBR1 in HOIP, Parkin and HHARI and potentially also other RBR proteins (see alignment in Supplementary Data 2). g, HHARI UBA domain (pink) binds HHARI RBR (light orange) in an equivalent position as Ub allo binding to HOIP, but promotes an inhibitory conformation of RING1-IBR that cannot bind the activated ubiquitin (PDB: 4KBL (ref. 11)). h, UBR3 is a regulatory hotspot and UBR3/UBR1 crosstalk. Parkin autoinhibition is facilitated by an UBL domain and is inherently linked to the equivalent of UBR3 and counteraction by phospho-ubiquitin binding. Different to Parkin, no structure of auto-inhibited HOIP RBR is available and thus the conformation of auto-inhibited HOIP is not known. However HHARI is, like HOIP, auto-inhibited by its UBA domain and the autoinhibited structure of HHARI has been solved previously (PDB: 4KBL (ref. 11)). This structure reveals that unlike the UBL of Parkin, the UBA of HHARI directly utilizes the region of UBR3 for binding and autoinhibition, which includes the kink in h E2 and a relative RING1-IBR positioning that is incompatible with binding of Ub act as observed in this study, further underlying a regulatory 'hotspot' function of the RBR UBR3/UBR1. Left, the UBA domain (pink) of HHARI utilizes an anti-parallel β-sheet anchor with strand β2 of the HHARI IBR (light orange) positioning the UBA to induce a kink in helix h E2 compared to its conformation in active HOIP (magenta) and counteracting the formation of a productive UBR3 and UBR1. Right, binding of the Ub allo to UBR3 in mode 2 utilizes a parallel β-sheet anchor (centred around the di-Arg binding interaction) with strand β2 of the IBR in active HOIP (magenta) inducing a straight conformation of h E2 and a conformation of UBR1 suited to bind the activated ubiquitin of the E2~Ub act conjugate. Putative shifts for an analogous UBR1 formed in HHARI are indicated. Of note, the structure of auto-inhibited HOIP is not known and therefore the placement of the UBA in the schematic illustration of Extended Data Fig. 10 is deduced based on the similar auto-inhibition of HOIP and HHARI by their UBA domains, which still needs to be demonstrated.
